Castle Hook Partners’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding HCAT
RP
Castle Hook Partners's HCAT Position: Q1 2022 in Review
Castle Hook Partners sold out of Health Catalyst (HCAT) in Q1 2022, closing a stake of 36,253 shares — an estimated $1.44M sold.
Castle Hook Partners first reported a position in HCAT in Q3 2021 and held it in 2 quarters. The position peaked at $3.73M in Q3 2021. 185 funds tracked by Wall St. Rank hold HCAT as of Q1 2022.
- Castle Hook Partners reported no remaining Health Catalyst position as of Q1 2022 after selling out during the quarter.
- Castle Hook Partners sold 36,253 Health Catalyst shares in Q1 2022, an estimated $1.44M.
- Castle Hook Partners first reported a position in Health Catalyst in Q3 2021 and held it in 2 quarters.
- Castle Hook Partners's Health Catalyst position peaked at $3.73M in Q3 2021.
- 185 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2022.
Based on Castle Hook Partners's 13F filing for Q1 2022, filed 13 May 2022.